Table 4 Summary of adverse events according to gender.

From: The effects of safinamide according to gender in Chinese parkinsonian patients

 

Females (n = 128)

Males (n = 177)

p-value†

Any AE

82 (64.0%)

96 (54.2%)

0.0996

Dizziness

15 (11.7%)

15 (8.4%)

0.4363

Dyskinesia

10 (7.8%)

14 (7.9%)

1.0000

Nausea

9 (7.0%)

5 (2.8%)

0.0998

Back pain

7 (5.4%)

8 (4.5%)

0.7909

Constipation

7 (5.4%)

7 (3.9%)

0.5860

  1. Each subject is counted at most once within each primary system organ class and preferred term. Adverse events were classified according to Medical Dictionary for Regulatory Activities (MedDRA) version 23.1. Percentages are calculated on the number of subjects in the safety analysis set by investigational product.
  2. AE adverse event, n number of subjects, % percentages of subjects.
  3. †Fisher’s Exact Test.
Back to article page